InnerVision scanner debuts with 510(k)

Article

Another new entrant in the low-field MRI sweepstakes, InnerVisionMRI of London, England, displayed impeccable timing by receiving510(k) clearance for its 0.14-tesla permanent magnet scanner justweeks before the RSNA meeting (SCAN 11/20/96). The scanner

Another new entrant in the low-field MRI sweepstakes, InnerVisionMRI of London, England, displayed impeccable timing by receiving510(k) clearance for its 0.14-tesla permanent magnet scanner justweeks before the RSNA meeting (SCAN 11/20/96). The scanner willbe displayed as Ortho 8000 in the booth of Vision Medical Servicesof Ontario, CA, which has U.S. rights to the system.

Vision will emphasize Ortho 8000's small footprint and minimalsiting requirements, its open-aperture magnet, and affordableprice and operating costs. The system will be targeted at orthopedic,pediatric, and interventional applications.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.